Serotype O:19 C. jejuni strains are overrepresented in GBS-associated strains in the US and Germany and demonstrate significant resistance to killing by normal human serum.
Authors
No takes yet. Share an insight, caveat, or question.
O:19 strains may contribute to GBS risk via serum resistance; hypothesis-generating and requires prospective human validation before any clinical inference.
Allos et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: